115450 — HLB Therapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩876bn
- KR₩865bn
- KR₩54bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17,180 | -17,401 | -17,764 | -12,104 | -3,079 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 8,947 | 8,369 | 7,140 | 3,800 | -7,322 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2,002 | -3,320 | -2,345 | -2,170 | 5,249 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -5,543 | -11,651 | -11,268 | -8,809 | 3,327 |
Capital Expenditures | -10,729 | -8,070 | -3,933 | -5,588 | -5,760 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -4,955 | -9,511 | 18,286 | -36,343 | -14,400 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -15,685 | -17,580 | 14,353 | -41,930 | -20,160 |
Financing Cash Flow Items | — | — | — | -7.08 | -14.6 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 47,756 | -32.4 | 82,854 | -3,318 | -5,281 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 26,544 | -29,268 | 85,943 | -54,052 | -22,112 |